The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. (2012)
- Authors:
- USP affiliated authors: MACEDO, CAROLINA SALES VIEIRA - FMRP ; REIS, ROSANA MARIA DOS - FMRP ; SÁ, MARCOS FELIPE SILVA DE - FMRP ; FERRIANI, RUI ALBERTO - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.contraception.2011.12.11
- Subjects: SÍNDROME DO OVÁRIO POLICÍSTICO; DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS; DOENÇAS CARDIOVASCULARES
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2012
- Source:
- Título: Contraception
- ISSN: 0010-7824
- Volume/Número/Paginação/Ano: v. 86, n. 3, p. 268-275, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
VIEIRA, Carolina Sales et al. The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception, v. 86, n. 3, p. 268-275, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2011.12.11. Acesso em: 29 dez. 2025. -
APA
Vieira, C. S., Martins, W. de P., Fernandes, J. B. F., Soares, G. M., Reis, R. M. dos, Sá, M. F. S. de, & Ferriani, R. A. (2012). The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception, 86( 3), 268-275. doi:10.1016/j.contraception.2011.12.11 -
NLM
Vieira CS, Martins W de P, Fernandes JBF, Soares GM, Reis RM dos, Sá MFS de, Ferriani RA. The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. [Internet]. Contraception. 2012 ; 86( 3): 268-275.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.contraception.2011.12.11 -
Vancouver
Vieira CS, Martins W de P, Fernandes JBF, Soares GM, Reis RM dos, Sá MFS de, Ferriani RA. The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. [Internet]. Contraception. 2012 ; 86( 3): 268-275.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.contraception.2011.12.11 - Effects of resisted physical training on muscle strength gain, body composition and metabolic repercussions in women with polycystic ovary syndrome
- Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
- Nutritional counseling promotes changes in the dietary habits of overweight and obese adolescents with polycystic ovary syndrome
- Serum leptin levels in healthy postmenopausal women receiving raloxifene
- Atualização sobre a influência dos esteróides sexuais na qualidade da voz
- Complicações da captação de oócitos pela técnica transvaginal
- Cardiovascular risk factors are reduced with a low dose of acarbose in obese patients with polycystic ovary syndrome
- Impact of physical resistance training on the sexual function of women with polycystic ovary syndrome
- Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women
- Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome
Informações sobre o DOI: 10.1016/j.contraception.2011.12.11 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
